Addex Therapeutics Ltd
APE · BX · CHF
CHF 0.0200
−0.004 −16.67%todayNot financial advice.
- Open
- 0.0200
- Day range
- 0.0200 - 0.0200
- 52-week range
- 0.0200 - 0.0540
- Volume
- 250
- Market cap
- 3.29M
- P/E ratio
- —
- EPS
- -0.07
- Dividend yield
- 0.00%
- Beta
- 0.78
Performance
W
−16.67%
1M
−48.72%
3M
−55.56%
6M
−56.52%
YTD
−62.26%
Y
−73.33%
5Y
−98.75%
All
−98.75%
In the news
Oct 8
Addex Therapeutics Spin-Out Neurosterix Completes Phase 1 Trial for Schizophrenia Drug
Neurosterix completed a Phase 1 study of its schizophrenia candidate NTX-253, marking an early milestone for 20% owner Addex Therapeutics.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/BX-APE" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Addex Therapeutics Ltd (APE) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/BX-APE">APE stock price</a> by FreeTheAI Stocks</p>